← Back
Data updated: Mar 10, 2026
DURAMED PHARMS BARR
CardiovascularNeurologyDermatology
DURAMED PHARMS BARR is a generic drug manufacturer focused on Cardiovascular, Neurology, Dermatology.
1983
Since
35
Drugs
-
Trials
415
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PROPRANOLOL HYDROCHLORIDE 2026-01-27
OXYCODONE AND ACETAMINOPHEN 2026-01-12
Labeling
OXYCODONE AND ACETAMINOPHEN 2026-01-06
Labeling
LOPERAMIDE HYDROCHLORIDE 2025-12-29
OXYCODONE AND ACETAMINOPHEN 2025-12-29
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-29
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-29
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-23
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-23
Labeling
OXYCODONE AND ACETAMINOPHEN 2025-12-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
2 drugs
Neurology 25%
1 drugs
Dermatology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Active (13)
Discontinued (21)
OXYCODONE AND ACETAMINOPHEN ACETAMINOPHEN AND CODEINE PHOSPHATE MEPERIDINE HYDROCHLORIDE HALOPERIDOL PREDNISONE METHYLPREDNISOLONE PHENTERMINE HYDROCHLORIDE INDOMETHACIN MEDROXYPROGESTERONE ACETATE ISONIAZID CLONIDINE HYDROCHLORIDE TEMAZEPAM METHYLDOPA ESTROPIPATE AMINOPHYLLINE AVIANE-21 ENPRESSE-21 CYPROHEPTADINE HYDROCHLORIDE TOLAZAMIDE GYNODIOL PROPRANOLOL HYDROCHLORIDE & HYDROCHLOROTHIAZIDE
Company Info
- First Approval
- 1983-03-17
- Latest
- 2024-05-31
- Applications
- 68